Histologic Subtypes and Response to PD-1/PD-L1 Blockade in Advanced Urothelial Cancer: A Retrospective Study

PURPOSE: Urinary tract cancer can be pure urothelial carcinoma (PUC), pure non-UC, or variant UC (VUC, defined here as mixed UC). Little is known regarding outcomes for patients with VUC receiving immune checkpoint inhibitors (ICI). We hypothesized that VUC does not compromise ICI efficacy in patien...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:J Urol
المؤلفون الرئيسيون: Miller, Natalie J, Khaki, Ali Raza, Diamantopoulos, Leonidas N, Bilen, Mehmet A, Santos, Victor, Agarwal, Neeraj, Morales-Barrera, Rafael, Devitt, Michael, Nelson, Ariel, Hoimes, Christopher J, Shreck, Evan, Assi, Hussein, Gartrell, Benjamin A, Sankin, Alex, Rodriguez-Vida, Alejo, Lythgoe, Mark, Pinato, David J, Drakaki, Alexandra, Joshi, Monika, Isaacsson Velho, Pedro, Hahn, Noah, Liu, Sandy, Alonso Buznego, Lucia, Duran, Ignacio, Moses, Marcus, Jain, Jayanshu, Murgic, Jure, Barata, Pedro, Tripathi, Abhishek, Zakharia, Yousef, Galsky, Matthew D, Sonpavde, Guru, Yu, Evan Y, Lyman, Gary H, Grivas, Petros
التنسيق: Artigo
اللغة:Inglês
منشور في: 2020
الموضوعات:
Article
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC7289665/
https://ncbi.nlm.nih.gov/pubmed/31971495
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JU.0000000000000761
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة